H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.4% of adults in Pembroke Pines have diagnosed diabetes — 1.4 points above the U.S. 12% figure. Census population 171,178. Florida Medicare wound biologics: First Coast Service Options (JN). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Pembroke Pines clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Pembroke Pines storefront.
Biologic Therapy for Osteoarthritis in Pembroke Pines, FL for clinics & physicians. Biologic therapy optio… Compliance support & pricing — contact Hawk Medical.
17.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 13.4% of adults in Pembroke Pines have diagnosed diabetes — 1.4 points above the U.S. 12% figure. Population 171,178. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JN documentation are ready before the first application of osteoarthritis biologic therapy.
National Biologic Therapy for Osteoarthritis notes (how the product actually works)17.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city under 250k with 171,178 residents will still mix those payers. CDC PLACES (2023, crude) estimates 13.4% of adults in Pembroke Pines have diagnosed diabetes — 1.4 points above the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Pembroke Pines trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 13.4% of adults in Pembroke Pines have diagnosed diabetes — 1.4 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 13.4% of adults — 1.4 points above the U.S. 12% figure. Obesity is 29%; arthritis is 22.2%. That is place-level BRFSS modeling, not a clinic census and not a Pembroke Pines trial.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
Florida is in CMS MAC JN, administered by First Coast Service Options. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Bring specialty, monthly joint / regenerative volume, and whether you bill JN FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 13.4% diabetes and 22.2% arthritis for Pembroke Pines — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Pembroke Pines, FL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Pembroke Pines is JN geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Pembroke Pines — 1.4 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Florida Part B wound biologics follow this contractor (siblings: no other states). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Pembroke Pines. Useful for joint-program math; still needs a diagnosis and privileging.
No Pembroke Pines storefront. Joe Bradley is an active practice owner. osteoarthritis biologic therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.